Stanley Druckenmiller at CNBC's Delivering Alpha on Sept. 28, 2022.Scott Mlyn | CNBCA version of this article first appeared in CNBC's Inside Wealth newsletter...
The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday. The...
Psilocybin mushrooms stand ready for harvest in a humidified "fruiting chamber." John Moore | Getty ImagesThursday's announcement that Eli Lilly will acquire AtaiBeckley, a...
AstraZeneca's failed late-stage trial for Wainua was never expected to have a major financial impact on the company.Most analysts estimate the trial miss wiped...
Moderna's expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty following the Covid-19 pandemic,...
